Surgery Partners Inc
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
SGRY$26.73+1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, dollars in millions)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net income | $24.3 | $1.2 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 33.7 | 33.7 |
| Non-cash lease expense | 9.0 | 9.0 |
| Non-cash interest expense, net | 1.5 | 6.5 |
| Equity-based compensation expense | 4.9 | 4.2 |
| Net loss on disposals, consolidations and deconsolidations | 1.5 | 10.5 |
| Deferred income taxes | 2.5 | (1.8) |
| Equity in earnings of unconsolidated affiliates, net of distributions received | 1.0 | (0.2) |
| Changes in operating assets and liabilities, net of acquisitions and divestitures: | ||
| Accounts receivable | 5.4 | 8.8 |
| Other operating assets and liabilities | (43.1) | 2.6 |
| Net cash provided by operating activities | 40.7 | 74.5 |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (21.0) | (24.3) |
| Payments for acquisitions, net of cash acquired | (54.6) | (40.7) |
| Proceeds from disposals of facilities and other assets | 1.5 | 8.0 |
| Purchases of equity investments | (2.0) | (9.6) |
| Other investing activities | (7.0) | (4.1) |
| Net cash used in investing activities | (83.1) | (70.7) |
| Cash flows from financing activities: | ||
| Principal payments on long-term debt | (120.2) | (15.9) |
| Borrowings of long-term debt | 192.5 | 15.9 |
| Payments of debt issuance costs | — | (1.3) |
| Distributions to non-controlling interest holders | (40.5) | (41.9) |
| Proceeds related to ownership transactions with non-controlling interest holders | 1.4 | 5.1 |
| Other financing activities | (1.5) | (3.1) |
| Net cash provided by (used in) financing activities | 31.7 | (41.2) |
| Net decrease in cash and cash equivalents | (10.7) | (37.4) |
| Cash and cash equivalents at beginning of period | 195.9 | 282.9 |
| Cash and cash equivalents at end of period | $185.2 | $245.5 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.